Abstract:Background: Parvovirus B19 (B19V) infection is a rare cause of severe anemia in liver transplant recipients. However, few studies have systematically reviewed reported cases and summarized experience in managing this disease. Objective: We described a retrospective case series of eight adult liver transplant recipients with B19V-associated severe anemia and performed a literature review of epidemiology, etiology, clinical courses, diagnosis, treatment options available, and outcomes of B19V-associated anemia in adult liver transplant recipients. Patients and Methods: We systematically reviewed articles describing adult liver transplant recipients with B19V-associated anemia from PubMed and ScienceDirect databases from database inception to May 2022. Results: Eight articles containing 23 cases were identified in addition to eight cases from our center for a total of 31 patients (mean age, 45.7 ± 9.7 years; 74.2% male). Eighty-seven percent developed transfusion-dependent anemia within two months after liver transplantation (LT). Fever and progressive anemia are among the major manifestations. Intravenous immunoglobulin (IVIG)-based therapy was given to all patients and the treatment protocols varied among different centers. Except for two cases who died of comorbidities, 17 patients obtained long-term recovery from anemia after one course of treatment and six (19%) experienced relapses that were reversed by repeated courses of IVIG therapy. Two recipients presented with IVIG-associated side effects and two developed acute cellular rejection (ACR) after reduction of immunosuppression. Conclusions: B19V infection should be suspected early as a cause of severe anemia of unknown etiology in adult liver transplant recipients. The clearance of B19V typically lags behind recovery of anemia, and inadequate clearance of virus after cessation of IVIG appears to be a potential risk of anemia recurrence. Moreover, more attention should be paid to the side effects of high-dose IVIG infusion and ACR because of reduction of immunosuppression.

Parvovirus B19 infection in a liver transplant recipient: case report and review in organ transplant recipients

Case Report: Parvovirus B19 infection complicated by hemophagocytic lymphohistiocytosis in a heart-lung transplant patient

Parvovirus B19-Associated Severe Anemia in Adult Liver Transplant Recipients: A Case Series and Review of the Literature

Parvovirus B19 Infection due to over Immunosuppression in Kidney Transplant Recipients: Case Reports and Literature Review

Parvovirus B19-induced Severe Anemia in Heart Transplant Recipient

The Detection, Treatment of Parvovirus B19 Infection Induced Anemia in Solid Organ Transplants: A Case Series and Literature Review of 194 Patients.

Donor-Derived Human Parvovirus B19 Infection in Kidney Transplantation

Acute Liver Failure and Myelosuppression Due to Parvovirus B19 Infection: A Case Report

Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation

Pure Red Cell Apalsia Caused by Infection of Human Parvovirus B19 Post-Renal Transplantation: 8 Cases Report and Review

Two Cases of Human Parvovirus B19 Infection-Associated Anemia after Pediatric Liver Transplantation

Human parvovirus B19 in solid organ transplantation: Guidelines from the American society of transplantation infectious diseases community of practice

Parvovirus B19 infection in patients after renal transplantation :a report of 22 cases

Parvovirus B19 Infection in Kidney Transplant Recipients: A Prospective Study in a Teaching Hospital in Shanghai, China.

Managing recurrent parvovirus B19-associated anemia after a pediatric kidney transplant

Clinical Characteristics of Human Parvovirus B19 Infection after Allogeneic Stem Cell Transplantation

Human parvovirus B19 infection-associated anemia after liver transplantation: three case reports with a literature review

Diagnosis and Treatment of Pure Red Cell Aplasia Caused by Human Parvovirus B19 after Liver Transplantation: Report of One Case and Literature Review

Human Parvovirus B19 Infection Induced Pure Red Cell Aplasia in Liver Transplant Recipients

ABO-incompatible living donor kidney transplantation failure due to acute blood group antibody-dependent rejection triggered by human parvovirus B19 infection: a case report and literature review

Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.